Celeste Thomas to Diabetes Mellitus, Type 2
This is a "connection" page, showing publications Celeste Thomas has written about Diabetes Mellitus, Type 2.
Connection Strength
0.852
-
Broadening Access to Continuous Glucose Monitoring for Patients With Type 2 Diabetes. JAMA. 2021 06 08; 325(22):2255-2257.
Score: 0.366
-
Metformin nephrotoxicity insights: will they change clinical management? J Diabetes. 2014 Mar; 6(2):111-2.
Score: 0.219
-
Longer-term Benefits and Risks of Sodium-Glucose Cotransporter-2 Inhibitors in Type 2 Diabetes: a Systematic Review and Meta-analysis. J Gen Intern Med. 2022 02; 37(2):439-448.
Score: 0.095
-
The Longer-Term Benefits and Harms of Glucagon-Like Peptide-1 Receptor Agonists: a Systematic Review and Meta-Analysis. J Gen Intern Med. 2022 02; 37(2):415-438.
Score: 0.093
-
Updates in Gestational Diabetes Prevalence, Treatment, and Health Policy. Curr Diab Rep. 2019 05 09; 19(6):33.
Score: 0.079